Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Pidotimod). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Pidomod 400 is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Acute Phase: Dose in adults: Take 2 tablets of 400 mg or 1 tablet of 800 mg, twice a day, two hours before or two hours after food and for 15 days. Dose in the elderly and children: Take 1 tablet of 400 mg, twice a day, two hours before or two hours after food and for 15 days. Prophylactic Phase: Dose in adults: Take 2 tablets of 400 mg or 1 tablet of 800 mg, once a day, two hours before or two hours after food and for 60 days. Elderly and children: Take 1 tablet of 400 mg, 1 time a day, two hours before or two hours after food and for 60 days. Missed Dose: Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.
Side Effects
It is generally well tolerated, but diarrhea may rarely occur in some patients. At high doses and based on experience, sedation, ataxia, dyspnea, and cyanosis may occur.
Cautions & Contraindications
Warnings & Precautions
Inform the doctor if Patients are allergic to Pidomod or other medicines. Before taking this medicine, let the doctor know if he has kidney disease or diabetes. Doctor should also know about all other medications are taking, as many of these may make this medicine less effective or change how it works. And also, inform the doctor if Patients are pregnant or breastfeeding. Pidomod to be taken with caution, especially if patients are children below 12. In this case, doctor may adjust your dose depending on patient’s age. Consumption of alcohol with Pidomod is not advisable as it may cause unpleasant side effects. Do not smoke- it can make patients symptoms worse. does not cause any adverse effect of carcinogenesis. Nor have mutagenic, teratogenic and fertility alterations been found.
Contraindications
Should not be administered simultaneously with immunosuppressive treatment or in patients with known hypersensitivity to Pidotimod.